Speciality Meditech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 19-06-2024
- Paid Up Capital ₹ 0.10 M
as on 19-06-2024
- Company Age 25 Year, 11 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 1.60 M
as on 19-06-2024
- Revenue 24.80%
(FY 2020)
- Profit 14.82%
(FY 2020)
- Ebitda 159.52%
(FY 2020)
- Net Worth 14.58%
(FY 2020)
- Total Assets 27.17%
(FY 2020)
About Speciality Meditech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.60 M.
Madhuri Devi, Prem Bhardwaj, and Radha Sharma serve as directors at the Company.
- CIN/LLPIN
U24234RJ1999PTC015313
- Company No.
015313
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jan 1999
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- LocationJaipur, Rajasthan
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Speciality Meditech Private Limited offer?
Speciality Meditech Private Limited offers a wide range of products and services, including Hand Sanitizer & Disinfectant, Alcohol Based Hand Sanitizer, Pharmaceutical Medicine, Vitamin Tablets & Capsules, Methylcobalamin Tablets, Mineral Supplement, Iron Tablet, Office Automation Products & Devices, Barcode Printers, Amoxicillin drugs.
Who are the key members and board of directors at Speciality Meditech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhuri Devi  | Director | 08-Jan-1999 | Current |
| Prem Bhardwaj | Director | 04-Feb-2006 | Current |
| Radha Sharma | Director | 08-Jan-1999 | Current |
Financial Performance of Speciality Meditech.
Speciality Meditech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 24.8% increase. The company also saw a substantial improvement in profitability, with a 14.82% increase in profit. The company's net worth Soared by an impressive increase of 14.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Speciality Meditech?
In 2019, Speciality Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 19 Jul 2019 | ₹1.60 M | Open |
How Many Employees Work at Speciality Meditech?
Speciality Meditech has a workforce of 50 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Speciality Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Speciality Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
